{"id":76523,"date":"2026-10-22T20:37:30","date_gmt":"2026-10-22T20:37:30","guid":{"rendered":"https:\/\/www.stocktargetadvisor.com\/blog\/?p=76523"},"modified":"2026-10-22T20:37:30","modified_gmt":"2026-10-22T20:37:30","slug":"us-analyst-updates-october-22nd-2026","status":"publish","type":"post","link":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-22nd-2026\/","title":{"rendered":"US Analyst Updates: October 22nd, 2026"},"content":{"rendered":"

Analyst Ratings (USA)<\/strong><\/a><\/h2>\n

American analyst sentiment remains cautiously optimistic but increasingly selective, with strong interest in utilities, power generation, defence, healthcare, and infrastructure-related sectors. Positive ratings and higher price targets reflect confidence in resilient earnings, energy demand, and long-term growth opportunities, while downgrades and target reductions across consumer discretionary, technology, and industrial stocks highlight concerns over valuations, slowing demand, and macroeconomic uncertainty.<\/p>\n

Updates (418)<\/strong><\/h3>\n

4D Molecular Therapeutics (FDMT)<\/strong> \u2014 Citigroup reiterated its Buy rating.<\/p>\n

4D Molecular Therapeutics (FDMT)<\/strong> \u2014 HC Wainwright reiterated its Buy rating with a $36.00 price target.<\/p>\n

Abbott Laboratories (ABT)<\/strong> \u2014 Robert W. Baird maintained its Outperform rating and raised its price target to $123.00 from $121.00.<\/p>\n

Abbott Laboratories (ABT)<\/strong> \u2014 BTIG Research maintained its Buy rating and lowered its price target to $125.00 from $134.00.<\/p>\n

Abbott Laboratories (ABT)<\/strong> \u2014 JPMorgan Chase & Co. maintained its Overweight rating and lowered its price target to $118.00 from $120.00.<\/p>\n

Abbott Laboratories (ABT)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and lowered its price target to $125.00 from $130.00.<\/p>\n

Abbott Laboratories (ABT)<\/strong> \u2014 TD Cowen maintained its Buy rating and lowered its price target to $118.00 from $135.00.<\/p>\n

Abbott Laboratories (ABT)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and raised its price target to $119.00 from $112.00.<\/p>\n

Abercrombie & Fitch (ANF)<\/strong> \u2014 Wolfe Research initiated coverage with a Outperform rating and set a $181 price target.<\/p>\n

Aegon (AEG)<\/strong> \u2014 JPMorgan downgraded the stock from Overweight to Neutral.<\/p>\n

AeroVironment (AVAV)<\/strong> \u2014 Oppenheimer changed its rating from Buy to Outperform and set a $205.00 price target.<\/p>\n

AEVEX (AVEX)<\/strong> \u2014 Jefferies Financial Group reiterated its Buy rating.<\/p>\n

AEVEX (AVEX)<\/strong> \u2014 Oppenheimer initiated coverage with a Outperform rating and set a $21.00 price target.<\/p>\n

AEVEX (AVEX)<\/strong> \u2014 Piper Sandler maintained its Neutral rating and lowered its price target to $13.00 from $20.00.<\/p>\n

AEVEX (AVEX)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and lowered its price target to $22.00 from $26.00.<\/p>\n

AEVEX (AVEX)<\/strong> \u2014 UBS Group initiated coverage with a Outperform rating and set a $21.00 price target.<\/p>\n

AGCO (AGCO)<\/strong> \u2014 Oppenheimer maintained its Outperform rating and lowered its price target to $123.00 from $127.00.<\/p>\n

Agenus (AGEN)<\/strong> \u2014 Chardan Capital reiterated its Buy rating.<\/p>\n

Alaska Air Group (ALK)<\/strong> \u2014 BMO Capital Markets reiterated its Outperform rating with a price target of $42.00, revised from $50.00.<\/p>\n

Alaska Air Group (ALK)<\/strong> \u2014 Citigroup reiterated its Sell rating.<\/p>\n

Alaska Air Group (ALK)<\/strong> \u2014 JPMorgan Chase & Co. maintained its Overweight rating and lowered its price target to $74.00 from $92.00.<\/p>\n

Alaska Air Group (ALK)<\/strong> \u2014 Susquehanna maintained its Positive rating and lowered its price target to $43.00 from $50.00.<\/p>\n

Alaska Air Group (ALK)<\/strong> \u2014 The Goldman Sachs Group reiterated its Buy rating with a $52.00 price target.<\/p>\n

Albemarle (ALB)<\/strong> \u2014 Citigroup reiterated its Buy rating.<\/p>\n

Alcoa (AA)<\/strong> \u2014 Argus downgraded the stock from Buy to Hold.<\/p>\n

Align Technology (ALGN)<\/strong> \u2014 Mizuho maintained its Outperform rating and lowered its price target to $200.00 from $220.00.<\/p>\n

Alignment Healthcare (ALHC)<\/strong> \u2014 The Goldman Sachs Group reiterated its Buy rating with a $12.00 price target.<\/p>\n

Alliant Energy (LNT)<\/strong> \u2014 HSBC changed its rating from Buy to Hold and set a $69.50 price target.<\/p>\n

Alphabet (GOOGL)<\/strong> \u2014 Citizens Jmp maintained its Market Outperform rating and lowered its price target to $450.00 from $515.00.<\/p>\n

Ameren (AEE)<\/strong> \u2014 HSBC changed its rating from Hold to Buy and set a $119.10 price target.<\/p>\n

Ameren (AEE)<\/strong> \u2014 TD Cowen initiated coverage with a Hold rating and set a $114.00 price target.<\/p>\n

America Movil (AMX)<\/strong> \u2014 UBS Group reiterated its Buy rating with a $31.00 price target.<\/p>\n

American Eagle Outfitters (AEO)<\/strong> \u2014 Wolfe Research initiated coverage with a Peer Perform rating.<\/p>\n

American Electric Power (AEP)<\/strong> \u2014 HSBC initiated coverage with a Buy rating and set a $145.90 price target.<\/p>\n

American Electric Power (AEP)<\/strong> \u2014 Jefferies Financial Group reiterated its Buy rating with a $145.00 price target.<\/p>\n

Amneal Pharmaceuticals (AMRX)<\/strong> \u2014 JPMorgan Chase & Co. maintained its Overweight rating and raised its price target to $24.00 from $22.00.<\/p>\n

Annaly Capital Management (NLY)<\/strong> \u2014 Barclays set a price target with a price target of $21.00, revised from $24.00.<\/p>\n

Annaly Capital Management (NLY)<\/strong> \u2014 JPMorgan Chase & Co. maintained its Overweight rating and raised its price target to $19.50 from $19.00.<\/p>\n

Annaly Capital Management (NLY)<\/strong> \u2014 Royal Bank Of Canada set a price target with a price target of $21.00, revised from $25.00.<\/p>\n

Annaly Capital Management (NLY)<\/strong> \u2014 Wells Fargo & Company set a price target with a price target of $22.00, revised from $24.00.<\/p>\n

AT&T (T)<\/strong> \u2014 Argus reiterated its Buy rating with a $30.00 price target.<\/p>\n

AT&T (T)<\/strong> \u2014 Barclays maintained its Equal Weight rating and lowered its price target to $21.00 from $24.00.<\/p>\n

AT&T (T)<\/strong> \u2014 JPMorgan Chase & Co. maintained its Overweight rating and lowered its price target to $31.00 from $33.00.<\/p>\n

AT&T (T)<\/strong> \u2014 KeyCorp maintained its Overweight rating and lowered its price target to $33.00 from $36.00.<\/p>\n

AT&T (T)<\/strong> \u2014 Morgan Stanley reiterated its Overweight rating with a price target of $25.00, revised from $28.00.<\/p>\n

AT&T (T)<\/strong> \u2014 TD Cowen reiterated its Hold rating with a $33.00 price target.<\/p>\n

Ategrity Specialty (ASIC)<\/strong> \u2014 Barclays maintained its Overweight rating and lowered its price target to $27.00 from $28.00.<\/p>\n

Ategrity Specialty (ASIC)<\/strong> \u2014 Citigroup reiterated its Neutral rating.<\/p>\n

Ategrity Specialty (ASIC)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and lowered its price target to $29.00 from $31.00.<\/p>\n

Atlassian (TEAM)<\/strong> \u2014 Oppenheimer maintained its Outperform rating and raised its price target to $275.00 from $200.00.<\/p>\n

Avidity Biosciences (RNA)<\/strong> \u2014 Roth Capital initiated coverage with a Buy rating and set a $15.00 price target.<\/p>\n

BankUnited (BKU)<\/strong> \u2014 Royal Bank Of Canada maintained its Sector Perform rating and lowered its price target to $48.00 from $49.00.<\/p>\n

Barings Bdc (BBDC)<\/strong> \u2014 Raymond James Financial set a price target of $9.00.<\/p>\n

Beauty Health (SKIN)<\/strong> \u2014 Canaccord Genuity Group set a price target of $11.00.<\/p>\n

Biodesix (BDSX)<\/strong> \u2014 HC Wainwright reiterated its Buy rating.<\/p>\n

Biogen (BIIB)<\/strong> \u2014 Bank of America maintained its Neutral rating and raised its price target to $244.00 from $219.00.<\/p>\n

Biohaven (BHVN)<\/strong> \u2014 Robert W. Baird set a price target of $48.00.<\/p>\n

Blackstone (BX)<\/strong> \u2014 The Goldman Sachs Group reiterated its Neutral rating with a $128.00 price target.<\/p>\n

Block (XYZ)<\/strong> \u2014 BMO Capital Markets upgraded the stock from Market Perform to Outperform and set a $101 price target.<\/p>\n

Blue Owl Capital (OBDC)<\/strong> \u2014 Raymond James Financial set a price target of $11.00.<\/p>\n

Booking (BKNG)<\/strong> \u2014 BTIG Research reiterated its Buy rating with a $250.00 price target.<\/p>\n

Boot Barn (BOOT)<\/strong> \u2014 UBS Group reiterated its Buy rating with a $232.00 price target.<\/p>\n

Broadcom (AVGO)<\/strong> \u2014 Tigress Financial initiated coverage with a Buy rating and set a $600.00 price target.<\/p>\n

Brookfield Infrastructure Partners (BIP)<\/strong> \u2014 Canadian Imperial Bank of Commerce set a price target of $44.00.<\/p>\n

Builders FirstSource (BLDR)<\/strong> \u2014 William Blair downgraded the stock from Outperform to Market Perform.<\/p>\n

Burford Capital (BUR)<\/strong> \u2014 Wedbush reiterated its Neutral rating with a $3.65 price target.<\/p>\n

Burlington Stores (BURL)<\/strong> \u2014 Wolfe Research initiated coverage with a Outperform rating and set a $356 price target.<\/p>\n

Cameco (CCJ)<\/strong> \u2014 Truist Financial maintained its Buy rating and lowered its price target to $125.00 from $130.00.<\/p>\n

Candel Therapeutics (CADL)<\/strong> \u2014 Jefferies Financial Group initiated coverage with a Buy rating and set a $25.00 price target.<\/p>\n

Capital One Financial (COF)<\/strong> \u2014 UBS Group reiterated its Buy rating.<\/p>\n

Carlyle Secured Lending (CGBD)<\/strong> \u2014 Raymond James Financial set a price target of $11.00.<\/p>\n

CAVA Group (CAVA)<\/strong> \u2014 UBS Group reiterated its Buy rating.<\/p>\n

Celcuity (CELC)<\/strong> \u2014 Cantor Fitzgerald initiated coverage with a Overweight rating and set a $140.00 price target.<\/p>\n

Cencora (COR)<\/strong> \u2014 Robert W. Baird maintained its Outperform rating and raised its price target to $375.00 from $373.00.<\/p>\n

CenterPoint Energy (CNP)<\/strong> \u2014 HSBC initiated coverage with a Buy rating and set a $44.00 price target.<\/p>\n

CenterPoint Energy (CNP)<\/strong> \u2014 TD Cowen initiated coverage with a Buy rating and set a $47.00 price target.<\/p>\n

Centrus Energy (LEU)<\/strong> \u2014 Barclays set a price target of $150.00.<\/p>\n

Centrus Energy (LEU)<\/strong> \u2014 Truist Financial maintained its Buy rating and lowered its price target to $178.00 from $215.00.<\/p>\n

Cheesecake Factory (CAKE)<\/strong> \u2014 Robert W. Baird maintained its Neutral rating and raised its price target to $120.00 from $105.00.<\/p>\n

Chipotle Mexican Grill (CMG)<\/strong> \u2014 DA Davidson set a price target of $45.00.<\/p>\n

Choice Hotels International (CHH)<\/strong> \u2014 Morgan Stanley set a price target of $93.00.<\/p>\n

Chubb (CB)<\/strong> \u2014 Mizuho maintained its Neutral rating and raised its price target to $350.00 from $336.00.<\/p>\n

Chubb (CB)<\/strong> \u2014 Wells Fargo & Company maintained its Equal Weight rating and raised its price target to $366.00 from $343.00.<\/p>\n

Clean Harbors (CLH)<\/strong> \u2014 Robert W. Baird maintained its Outperform rating and raised its price target to $365.00 from $360.00.<\/p>\n

Cleanspark (CLSK)<\/strong> \u2014 Canaccord Genuity Group initiated coverage with a Buy rating and set a $20.00 price target.<\/p>\n

Cleveland-Cliffs (CLF)<\/strong> \u2014 Barclays maintained its Underweight rating and raised its price target to $12.00 from $11.00.<\/p>\n

Cleveland-Cliffs (CLF)<\/strong> \u2014 B. Riley Financial maintained its Buy rating and raised its price target to $18.00 from $15.00.<\/p>\n

Cleveland-Cliffs (CLF)<\/strong> \u2014 JPMorgan Chase & Co. maintained its Neutral rating and raised its price target to $13.00 from $12.00.<\/p>\n

CME Group (CME)<\/strong> \u2014 Barclays maintained its Equal Weight rating and raised its price target to $321.00 from $281.00.<\/p>\n

CME Group (CME)<\/strong> \u2014 CLSA set a price target of $367.00.<\/p>\n

CME Group (CME)<\/strong> \u2014 JPMorgan upgraded the stock from Underweight to Overweight and set a $367 price target.<\/p>\n

CME Group (CME)<\/strong> \u2014 Morgan Stanley set a price target with a price target of $359.00, revised from $337.00.<\/p>\n

CME Group (CME)<\/strong> \u2014 Piper Sandler reiterated its Overweight rating with a price target of $330.00, revised from $295.00.<\/p>\n

CME Group (CME)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and raised its price target to $333.00 from $315.00.<\/p>\n

CMS Energy (CMS)<\/strong> \u2014 HSBC changed its rating from Underperform to Hold and set a $69.00 price target.<\/p>\n

Community Trust Bancorp (CTBI)<\/strong> \u2014 Piper Sandler maintained its Neutral rating and lowered its price target to $75.00 from $81.00.<\/p>\n

Consolidated Edison (ED)<\/strong> \u2014 HSBC initiated coverage with a Hold rating and set a $104.00 price target.<\/p>\n

Constellation Energy (CEG)<\/strong> \u2014 HSBC initiated coverage with a Buy rating and set a $335 price target.<\/p>\n

Crescent Capital BDC (CCAP)<\/strong> \u2014 Raymond James Financial set a price target of $10.00.<\/p>\n

Crown Castle (CCI)<\/strong> \u2014 TD Cowen maintained its Buy rating and raised its price target to $98.00 from $92.00.<\/p>\n

CSX (CSX)<\/strong> \u2014 Bank of America maintained its Buy rating and raised its price target to $57.00 from $55.00.<\/p>\n

CSX (CSX)<\/strong> \u2014 JPMorgan Chase & Co. maintained its Overweight rating and raised its price target to $58.00 from $57.00.<\/p>\n

CSX (CSX)<\/strong> \u2014 Royal Bank Of Canada reiterated its Outperform rating with a price target of $54.00, revised from $53.00.<\/p>\n

CSX (CSX)<\/strong> \u2014 Sanford C. Bernstein reiterated its Market Perform rating with a $49.00 price target.<\/p>\n

CSX (CSX)<\/strong> \u2014 TD Cowen reiterated its Buy rating with a price target of $55.00, revised from $54.00.<\/p>\n

CSX (CSX)<\/strong> \u2014 UBS Group reiterated its Buy rating with a $60.00 price target.<\/p>\n

Cushman & Wakefield (CWK)<\/strong> \u2014 Citigroup reiterated its existing rating with a $11.83 price target.<\/p>\n

Cushman & Wakefield (CWK)<\/strong> \u2014 Citizens Jmp maintained its Market Outperform rating and lowered its price target to $16.00 from $19.00.<\/p>\n

Cybin (HELP)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and raised its price target to $22.00 from $16.00.<\/p>\n

Danaher (DHR)<\/strong> \u2014 Robert W. Baird maintained its Outperform rating and raised its price target to $254.00 from $246.00.<\/p>\n

Danaher (DHR)<\/strong> \u2014 Barclays maintained its Overweight rating and raised its price target to $260.00 from $255.00.<\/p>\n

Danaher (DHR)<\/strong> \u2014 Citigroup reiterated its Buy rating.<\/p>\n

Danaher (DHR)<\/strong> \u2014 JPMorgan Chase & Co. maintained its Overweight rating and raised its price target to $270.00 from $250.00.<\/p>\n

Danaher (DHR)<\/strong> \u2014 Stifel Nicolaus maintained its Buy rating and raised its price target to $260.00 from $220.00.<\/p>\n

Danaher (DHR)<\/strong> \u2014 TD Cowen maintained its Buy rating and raised its price target to $270.00 from $255.00.<\/p>\n

Danaher (DHR)<\/strong> \u2014 The Goldman Sachs Group reiterated its Buy rating with a $275.00 price target.<\/p>\n

Danaher (DHR)<\/strong> \u2014 UBS Group reiterated its Buy rating with a $260.00 price target.<\/p>\n

DarkHorse Technologies (DRK)<\/strong> \u2014 Maxim Group initiated coverage with a Buy rating and set a $6.00 price target.<\/p>\n

Deckers Outdoor (DECK)<\/strong> \u2014 Wolfe Research initiated coverage with a Peer Perform rating.<\/p>\n

Delek US (DK)<\/strong> \u2014 TD Cowen maintained its Buy rating and raised its price target to $90.00 from $85.00.<\/p>\n

DENTSPLY SIRONA (XRAY)<\/strong> \u2014 Mizuho maintained its Neutral rating and lowered its price target to $12.00 from $14.00.<\/p>\n

Dick\u2019s Sporting Goods (DKS)<\/strong> \u2014 Wolfe Research initiated coverage with a Outperform rating and set a $181 price target.<\/p>\n

Dime Community Bancshares (DCOM)<\/strong> \u2014 DA Davidson set a price target of $50.00.<\/p>\n

DraftKings (DKNG)<\/strong> \u2014 Moffett Nathanson reiterated its Neutral rating with a $22.00 price target.<\/p>\n

DTE Energy (DTE)<\/strong> \u2014 HSBC initiated coverage with a Hold rating and set a $135.00 price target.<\/p>\n

Duke Energy (DUK)<\/strong> \u2014 HSBC initiated coverage with a Hold rating and set a $123.00 price target.<\/p>\n

Dutch Bros (BROS)<\/strong> \u2014 RBC downgraded the stock from Outperform to Sector Perform with a price target of $46.00, revised from $70.00.<\/p>\n

East West Bancorp (EWBC)<\/strong> \u2014 Citigroup reiterated its Buy rating.<\/p>\n

Edison International (EIX)<\/strong> \u2014 HSBC initiated coverage with a Hold rating and set a $56.50 price target.<\/p>\n

Electra Therapeutics (ETRA)<\/strong> \u2014 JPMorgan Chase & Co. initiated coverage with a Overweight rating and set a $36.00 price target.<\/p>\n

Element Solutions (ESI)<\/strong> \u2014 Mizuho maintained its Neutral rating and raised its price target to $44.00 from $42.00.<\/p>\n

Elevance Health (ELV)<\/strong> \u2014 Robert W. Baird maintained its Neutral rating and raised its price target to $406.00 from $393.00.<\/p>\n

Elevance Health (ELV)<\/strong> \u2014 Barclays maintained its Overweight rating and raised its price target to $472.00 from $469.00.<\/p>\n

Elevance Health (ELV)<\/strong> \u2014 Guggenheim set a price target of $485.00.<\/p>\n

Elevance Health (ELV)<\/strong> \u2014 Royal Bank Of Canada maintained its Sector Perform rating and raised its price target to $455.00 from $424.00.<\/p>\n

Elevance Health (ELV)<\/strong> \u2014 UBS Group set a price target of $523.00.<\/p>\n

Enbridge (ENB)<\/strong> \u2014 Canadian Imperial Bank of Commerce reiterated its existing rating with a $47.94 price target.<\/p>\n

Entergy (ETR)<\/strong> \u2014 HSBC initiated coverage with a Buy rating and set a $123.50 price target.<\/p>\n

Equifax (EFX)<\/strong> \u2014 Argus upgraded the stock from Hold to Buy and set a $200 price target.<\/p>\n

Essential Properties Realty Trust (EPRT)<\/strong> \u2014 Raymond James Financial reiterated its Strong-Buy rating with a $37.00 price target.<\/p>\n

Essential Properties Realty Trust (EPRT)<\/strong> \u2014 Stifel Nicolaus maintained its Buy rating and lowered its price target to $32.50 from $36.00.<\/p>\n

Evergy (EVRG)<\/strong> \u2014 HSBC initiated coverage with a Buy rating and set a $92.00 price target.<\/p>\n

Evergy (EVRG)<\/strong> \u2014 TD Cowen initiated coverage with a Buy rating and set a $95.00 price target.<\/p>\n

Eversource Energy (ES)<\/strong> \u2014 HSBC initiated coverage with a Hold rating and set a $70.00 price target.<\/p>\n

Exelon (EXC)<\/strong> \u2014 HSBC initiated coverage with a Hold rating and set a $44.00 price target.<\/p>\n

Extreme Networks (EXTR)<\/strong> \u2014 Rosenblatt Securities reiterated its Buy rating with a $38.00 price target.<\/p>\n

Fifth Third Bancorp (FITB)<\/strong> \u2014 Citigroup reiterated its Buy rating.<\/p>\n

First Bancorp (FBNC)<\/strong> \u2014 Piper Sandler maintained its Neutral rating and raised its price target to $66.00 from $65.00.<\/p>\n

FirstEnergy (FE)<\/strong> \u2014 HSBC initiated coverage with a Buy rating and set a $50.00 price target.<\/p>\n

FirstEnergy (FE)<\/strong> \u2014 Jefferies Financial Group reiterated its Hold rating.<\/p>\n

Flutter Entertainment (FLUT)<\/strong> \u2014 Moffett Nathanson reiterated its Neutral rating with a $92.00 price target.<\/p>\n

Galaxy Digital (GLXY)<\/strong> \u2014 Maxim Group set a price target of $36.00.<\/p>\n

Gap (GAP)<\/strong> \u2014 Wolfe Research initiated coverage with a Peer Perform rating.<\/p>\n

Genpact (G)<\/strong> \u2014 Susquehanna maintained its Neutral rating and raised its price target to $40.00 from $37.00.<\/p>\n

Genuine Parts (GPC)<\/strong> \u2014 Argus maintained its Buy rating and lowered its price target to $150.00 from $156.00.<\/p>\n

Geopark (GPRK)<\/strong> \u2014 Jefferies Financial Group reiterated its Buy rating with a $13.50 price target.<\/p>\n

GSI Technology (GSIT)<\/strong> \u2014 Needham & Company LLC reiterated its Buy rating with a $9.00 price target.<\/p>\n

Halliburton (HAL)<\/strong> \u2014 UBS Group set a price target of $41.00.<\/p>\n

Heritage Financial (HFWA)<\/strong> \u2014 Raymond James Financial reiterated its Market Perform rating.<\/p>\n

HF Sinclair (DINO)<\/strong> \u2014 TD Cowen maintained its Hold rating and raised its price target to $110.00 from $100.00.<\/p>\n

indie Semiconductor (INDI)<\/strong> \u2014 B. Riley Financial maintained its Buy rating and lowered its price target with a $119.00 price target.<\/p>\n

Integra LifeSciences (IART)<\/strong> \u2014 BMO Capital Markets reiterated its Market Perform rating with a price target of $14.00, revised from $15.00.<\/p>\n

Integra LifeSciences (IART)<\/strong> \u2014 Citizens Jmp maintained its Market Outperform rating and lowered its price target to $22.00 from $25.00.<\/p>\n

Integra LifeSciences (IART)<\/strong> \u2014 JPMorgan Chase & Co. maintained its Underweight rating and lowered its price target to $14.00 from $17.00.<\/p>\n

Integra LifeSciences (IART)<\/strong> \u2014 Wells Fargo & Company set a price target with a price target of $13.00, revised from $15.00.<\/p>\n

Intercontinental Hotels Group (IHG)<\/strong> \u2014 Bank of America reiterated its Buy rating.<\/p>\n

International Business Machines (IBM)<\/strong> \u2014 Robert W. Baird maintained its Neutral rating and raised its price target to $260.00 from $230.00.<\/p>\n

International Business Machines (IBM)<\/strong> \u2014 Barclays maintained its Overweight rating and raised its price target to $277.00 from $262.00.<\/p>\n

International Business Machines (IBM)<\/strong> \u2014 BMO Capital Markets reiterated its Market Perform rating with a price target of $265.00, revised from $230.00.<\/p>\n

International Business Machines (IBM)<\/strong> \u2014 Citigroup reiterated its Buy rating.<\/p>\n

International Business Machines (IBM)<\/strong> \u2014 Jefferies Financial Group reiterated its Buy rating with a $280.00 price target.<\/p>\n

International Business Machines (IBM)<\/strong> \u2014 JPMorgan Chase & Co. maintained its Overweight rating and raised its price target to $269.00 from $250.00.<\/p>\n

International Business Machines (IBM)<\/strong> \u2014 Morgan Stanley set a price target with a price target of $240.00, revised from $238.00.<\/p>\n

International Business Machines (IBM)<\/strong> \u2014 Royal Bank Of Canada reiterated its Outperform rating with a $270.00 price target.<\/p>\n

International Business Machines (IBM)<\/strong> \u2014 Stifel Nicolaus maintained its Buy rating and raised its price target to $260.00 from $235.00.<\/p>\n

International Business Machines (IBM)<\/strong> \u2014 The Goldman Sachs Group reiterated its Buy rating with a $300.00 price target.<\/p>\n

International Business Machines (IBM)<\/strong> \u2014 Truist Financial set a price target of $260.00.<\/p>\n

International Business Machines (IBM)<\/strong> \u2014 UBS Group set a price target of $243.00.<\/p>\n

International Flavors & Fragrances (IFF)<\/strong> \u2014 Oppenheimer maintained its Outperform rating and raised its price target to $108.00 from $95.00.<\/p>\n

Ionic Digital (IOND)<\/strong> \u2014 Canaccord Genuity initiated coverage with a Buy rating and set a $119 price target.<\/p>\n

Ionis Pharmaceuticals (IONS)<\/strong> \u2014 BMO Capital Markets upgraded the stock from Market Perform to Outperform with a price target of $66.00, revised from $54.00.<\/p>\n

Ionis Pharmaceuticals (IONS)<\/strong> \u2014 HC Wainwright reiterated its Buy rating.<\/p>\n

JBS (JBS)<\/strong> \u2014 JPMorgan Chase & Co. maintained its Overweight rating and lowered its price target to $17.50 from $18.00.<\/p>\n

Kardigan (KARD)<\/strong> \u2014 Robert W. Baird initiated coverage with a Outperform rating and set a $43 price target.<\/p>\n

Karman (KRMN)<\/strong> \u2014 Oppenheimer initiated coverage with a Outperform rating and set a $40.00 price target.<\/p>\n

Karman (KRMN)<\/strong> \u2014 UBS Group set a price target of $40.00.<\/p>\n

Keurig Dr Pepper (KDP)<\/strong> \u2014 JPMorgan Chase & Co. maintained its Overweight rating and raised its price target to $39.00 from $38.00.<\/p>\n

Kinder Morgan (KMI)<\/strong> \u2014 BMO Capital Markets reiterated its Outperform rating with a price target of $37.00, revised from $36.00.<\/p>\n

Kinder Morgan (KMI)<\/strong> \u2014 Jefferies Financial Group reiterated its Hold rating.<\/p>\n

Kinder Morgan (KMI)<\/strong> \u2014 Mizuho maintained its Outperform rating and raised its price target to $39.00 from $37.00.<\/p>\n

Kinder Morgan (KMI)<\/strong> \u2014 Morgan Stanley set a price target of $39.00.<\/p>\n

Kinder Morgan (KMI)<\/strong> \u2014 TD Cowen maintained its Buy rating and raised its price target to $40.00 from $38.00.<\/p>\n

Kinder Morgan (KMI)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and raised its price target to $39.00 from $36.00.<\/p>\n

Knight-Swift Transportation (KNX)<\/strong> \u2014 JPMorgan Chase & Co. maintained its Neutral rating and raised its price target to $74.00 from $68.00.<\/p>\n

Knight-Swift Transportation (KNX)<\/strong> \u2014 Raymond James Financial reiterated its Strong-Buy rating with a $84.00 price target.<\/p>\n

Knight-Swift Transportation (KNX)<\/strong> \u2014 Stifel Nicolaus maintained its Buy rating and raised its price target to $92.00 from $90.00.<\/p>\n

Knight-Swift Transportation (KNX)<\/strong> \u2014 UBS Group reiterated its Buy rating.<\/p>\n

Knight-Swift Transportation (KNX)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and lowered its price target to $79.00 from $81.00.<\/p>\n

Kodiak AI (KDK)<\/strong> \u2014 Chardan Capital maintained its Buy rating and lowered its price target with a $4.50 price target.<\/p>\n

Kohl’s (KSS)<\/strong> \u2014 Gordon Haskett upgraded the stock from Hold to Buy and set a $27 price target.<\/p>\n

Kratos Defense & Security Solutions (KTOS)<\/strong> \u2014 Oppenheimer initiated coverage with a Outperform rating and set a $50.00 price target.<\/p>\n

Kyverna Therapeutics (KYTX)<\/strong> \u2014 HC Wainwright reiterated its Buy rating.<\/p>\n

Lam Research (LRCX)<\/strong> \u2014 Bank of America reiterated its Buy rating with a $345.00 price target.<\/p>\n

Lam Research (LRCX)<\/strong> \u2014 Citigroup reiterated its Buy rating.<\/p>\n

Lam Research (LRCX)<\/strong> \u2014 Mizuho maintained its Outperform rating and lowered its price target to $360.00 from $365.00.<\/p>\n

Lam Research (LRCX)<\/strong> \u2014 Morgan Stanley set a price target of $339.00.<\/p>\n

Lam Research (LRCX)<\/strong> \u2014 Needham & Company LLC maintained its Buy rating and lowered its price target to $290.00 from $390.00.<\/p>\n

Lam Research (LRCX)<\/strong> \u2014 UBS Group reiterated its Buy rating with a $400.00 price target.<\/p>\n

Las Vegas Sands (LVS)<\/strong> \u2014 Bank of America maintained its Neutral rating and lowered its price target to $45.00 from $50.00.<\/p>\n

Las Vegas Sands (LVS)<\/strong> \u2014 Barclays maintained its Overweight rating and lowered its price target to $50.00 from $57.00.<\/p>\n

Las Vegas Sands (LVS)<\/strong> \u2014 Mizuho maintained its Outperform rating and lowered its price target to $54.00 from $61.00.<\/p>\n

Las Vegas Sands (LVS)<\/strong> \u2014 Morgan Stanley set a price target with a price target of $49.00, revised from $55.00.<\/p>\n

Las Vegas Sands (LVS)<\/strong> \u2014 Stifel Nicolaus maintained its Buy rating and lowered its price target to $52.00 from $54.00.<\/p>\n

Las Vegas Sands (LVS)<\/strong> \u2014 The Goldman Sachs Group set a price target of $41.00.<\/p>\n

Las Vegas Sands (LVS)<\/strong> \u2014 Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to $40.00 from $44.00.<\/p>\n

Leonardo DRS (DRS)<\/strong> \u2014 Oppenheimer initiated coverage with a Outperform rating and set a $45.00 price target.<\/p>\n

Lithia Motors (LAD)<\/strong> \u2014 JPMorgan Chase & Co. maintained its Neutral rating and lowered its price target to $315.00 from $320.00.<\/p>\n

lululemon athletica (LULU)<\/strong> \u2014 Wolfe Research initiated coverage with a Underperform rating and set a $75.00 price target.<\/p>\n

Marathon Petroleum (MPC)<\/strong> \u2014 TD Cowen maintained its Buy rating and raised its price target to $478.00 from $450.00.<\/p>\n

Marriott Vacations Worldwide (VAC)<\/strong> \u2014 Morgan Stanley set a price target of $63.00.<\/p>\n

MasTec (MTZ)<\/strong> \u2014 The Goldman Sachs Group reiterated its Buy rating with a $274.00 price target.<\/p>\n

Medline (MDLN)<\/strong> \u2014 Mizuho maintained its Outperform rating and lowered its price target to $45.00 from $48.00.<\/p>\n

Mercury Systems (MRCY)<\/strong> \u2014 Oppenheimer initiated coverage with a Outperform rating and set a $90.00 price target.<\/p>\n

Meta Platforms (META)<\/strong> \u2014 Bank of America maintained its Buy rating and raised its price target to $845.00 from $810.00.<\/p>\n

Meta Platforms (META)<\/strong> \u2014 Barclays maintained its Overweight rating and raised its price target to $880.00 from $780.00.<\/p>\n

Meta Platforms (META)<\/strong> \u2014 BMO Capital Markets reiterated its Market Perform rating with a price target of $685.00, revised from $580.00.<\/p>\n

Meta Platforms (META)<\/strong> \u2014 Cantor Fitzgerald maintained its Overweight rating and raised its price target to $860.00 from $840.00.<\/p>\n

Meta Platforms (META)<\/strong> \u2014 Citizens Jmp reiterated its Market Outperform rating with a $885.00 price target.<\/p>\n

Meta Platforms (META)<\/strong> \u2014 Evercore reiterated its existing rating with a $644.56 price target.<\/p>\n

Meta Platforms (META)<\/strong> \u2014 Guggenheim reiterated its Buy rating with a $850.00 price target.<\/p>\n

Meta Platforms (META)<\/strong> \u2014 JPMorgan Chase & Co. maintained its Overweight rating and raised its price target to $940.00 from $920.00.<\/p>\n

Meta Platforms (META)<\/strong> \u2014 KeyCorp maintained its Overweight rating and raised its price target to $905.00 from $900.00.<\/p>\n

Meta Platforms (META)<\/strong> \u2014 Mizuho maintained its Outperform rating and raised its price target to $950.00 from $750.00.<\/p>\n

Meta Platforms (META)<\/strong> \u2014 Monness Crespi & Hardt reiterated its Buy rating with a $875.00 price target.<\/p>\n

Meta Platforms (META)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and lowered its price target to $850.00 from $875.00.<\/p>\n

Meta Platforms (META)<\/strong> \u2014 Pivotal Research maintained its Buy rating and raised its price target to $960.00 from $930.00.<\/p>\n

Meta Platforms (META)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and raised its price target to $800.00 from $770.00.<\/p>\n

Meta Platforms (META)<\/strong> \u2014 Scotiabank maintained its Sector Perform rating and raised its price target to $650.00 from $600.00.<\/p>\n

Meta Platforms (META)<\/strong> \u2014 Susquehanna maintained its Positive rating and raised its price target to $850.00 from $650.00.<\/p>\n

Meta Platforms (META)<\/strong> \u2014 TD Cowen maintained its Buy rating and lowered its price target to $850.00 from $865.00.<\/p>\n

Meta Platforms (META)<\/strong> \u2014 The Goldman Sachs Group reiterated its Buy rating with a $885.00 price target.<\/p>\n

Meta Platforms (META)<\/strong> \u2014 UBS Group reiterated its Outperform rating with a $920.00 price target.<\/p>\n

Meta Platforms (META)<\/strong> \u2014 Wedbush maintained its Neutral rating and raised its price target to $730.00 from $700.00.<\/p>\n

Meta Platforms (META)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and lowered its price target to $995.00 from $1,000.00.<\/p>\n

Microchip Technology (MCHP)<\/strong> \u2014 B. Riley Financial maintained its Buy rating and lowered its price target to $98.00 from $108.00.<\/p>\n

Micron Technology (MU)<\/strong> \u2014 Needham & Company LLC reiterated its Buy rating with a $1,650.00 price target.<\/p>\n

Micron Technology (MU)<\/strong> \u2014 Rosenblatt Securities reiterated its Buy rating with a $1,900.00 price target.<\/p>\n

MidCap Financial Investment (MFIC)<\/strong> \u2014 Raymond James Financial set a price target of $9.50.<\/p>\n

Monster Beverage (MNST)<\/strong> \u2014 Citigroup reiterated its Buy rating.<\/p>\n

Monster Beverage (MNST)<\/strong> \u2014 Stifel Nicolaus set a price target of $52.00.<\/p>\n

Moody’s (MCO)<\/strong> \u2014 Bank of America maintained its Buy rating and lowered its price target to $575.00 from $580.00.<\/p>\n

Moody’s (MCO)<\/strong> \u2014 BMO Capital Markets reiterated its Market Perform rating with a price target of $511.00, revised from $490.00.<\/p>\n

Moody’s (MCO)<\/strong> \u2014 Morgan Stanley set a price target of $480.00.<\/p>\n

Moody’s (MCO)<\/strong> \u2014 Stifel Nicolaus maintained its Buy rating and lowered its price target to $537.00 from $550.00.<\/p>\n

Moody’s (MCO)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and lowered its price target to $595.00 from $597.00.<\/p>\n

Morgan Stanley Direct Lending Fund (MSDL)<\/strong> \u2014 Raymond James Financial set a price target of $15.00.<\/p>\n

Murphy USA (MUSA)<\/strong> \u2014 JPMorgan Chase & Co. maintained its Overweight rating and lowered its price target to $626.00 from $633.00.<\/p>\n

MYR Group (MYRG)<\/strong> \u2014 The Goldman Sachs Group reiterated its Neutral rating with a $331.00 price target.<\/p>\n

Nano Nuclear Energy (NNE)<\/strong> \u2014 Truist Financial maintained its Hold rating and lowered its price target to $19.00 from $22.00.<\/p>\n

Nasdaq (NDAQ)<\/strong> \u2014 Jefferies Financial Group reiterated its Hold rating.<\/p>\n

Neptune Insurance (NP)<\/strong> \u2014 Morgan Stanley set a price target of $35.00.<\/p>\n

Netflix (NFLX)<\/strong> \u2014 Argus set a price target with a price target of $95.00, revised from $120.00.<\/p>\n

Netflix (NFLX)<\/strong> \u2014 Wolfe Research downgraded the stock from Outperform to Peer Perform.<\/p>\n

NETSTREIT (NTST)<\/strong> \u2014 Stifel Nicolaus maintained its Buy rating and lowered its price target to $21.25 from $23.50.<\/p>\n

Newell Brands (NWL)<\/strong> \u2014 UBS Group reiterated its Neutral rating.<\/p>\n

Newmark Group (NMRK)<\/strong> \u2014 Citigroup reiterated its existing rating with a $11.78 price target.<\/p>\n

Newmark Group (NMRK)<\/strong> \u2014 Citizens Jmp maintained its Market Outperform rating and lowered its price target to $17.00 from $22.00.<\/p>\n

NextEra Energy (NEE)<\/strong> \u2014 BTIG Research set a price target of $106.00.<\/p>\n

NextEra Energy (NEE)<\/strong> \u2014 HSBC set a price target of $103.00.<\/p>\n

NIKE (NKE)<\/strong> \u2014 Barclays reiterated its Overweight rating with a price target of $45.00, revised from $37.00.<\/p>\n

NIKE (NKE)<\/strong> \u2014 BTIG Research reiterated its Buy rating with a $50.00 price target.<\/p>\n

NIKE (NKE)<\/strong> \u2014 UBS Group reiterated its Neutral rating.<\/p>\n

Nike (NKE)<\/strong> \u2014 Wolfe Research initiated coverage with a Underperform rating and set a $28 price target.<\/p>\n

NiSource (NI)<\/strong> \u2014 HSBC initiated coverage with a Buy rating and set a $49.50 price target.<\/p>\n

Northern Trust (NTRS)<\/strong> \u2014 Barclays maintained its Equal Weight rating and raised its price target to $194.00 from $189.00.<\/p>\n

Northern Trust (NTRS)<\/strong> \u2014 Morgan Stanley reiterated its Underweight rating with a $177.00 price target.<\/p>\n

Northpointe Bancshares (NPB)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and lowered its price target to $19.50 from $20.00.<\/p>\n

Northrop Grumman (NOC)<\/strong> \u2014 Barclays maintained its Underweight rating and raised its price target to $430.00 from $419.00.<\/p>\n

Northwest Natural Gas (NWN)<\/strong> \u2014 Mizuho initiated coverage with a Neutral rating and set a $51.00 price target.<\/p>\n

Northwest Natural Gas (NWN)<\/strong> \u2014 Morgan Stanley downgraded the stock to Buy.<\/p>\n

NRG Energy (NRG)<\/strong> \u2014 HSBC initiated coverage with a Buy rating and set a $179.00 price target.<\/p>\n

NuScale Power (SMR)<\/strong> \u2014 Truist Financial maintained its Hold rating and lowered its price target to $8.00 from $10.00.<\/p>\n

Nutrien (NTR)<\/strong> \u2014 Oppenheimer maintained its Outperform rating and lowered its price target to $78.00 from $80.00.<\/p>\n

Oklo (OKLO)<\/strong> \u2014 Truist Financial maintained its Hold rating and lowered its price target to $31.00 from $51.00.<\/p>\n

Old National Bancorp (ONB)<\/strong> \u2014 JPMorgan Chase & Co. maintained its Overweight rating and lowered its price target to $29.00 from $30.00.<\/p>\n

Old National Bancorp (ONB)<\/strong> \u2014 TD Cowen maintained its Buy rating and lowered its price target to $29.00 from $30.00.<\/p>\n

Omega Healthcare Investors (OHI)<\/strong> \u2014 Citigroup upgraded the stock from Buy to Outperform.<\/p>\n

Omega Healthcare Investors (OHI)<\/strong> \u2014 Citizens upgraded the stock from Market Perform to Market Outperform and set a $52 price target.<\/p>\n

On Holding (ONON)<\/strong> \u2014 Wolfe Research initiated coverage with a Outperform rating and set a $47 price target.<\/p>\n

onsemi (ON)<\/strong> \u2014 B. Riley Financial maintained its Buy rating and lowered its price target to $105.00 from $127.00.<\/p>\n

Opus Genetics (IRD)<\/strong> \u2014 Chardan Capital reiterated its Buy rating with a price target of $9.00, revised from $16.00.<\/p>\n

Oracle (ORCL)<\/strong> \u2014 Cantor Fitzgerald reiterated its Overweight rating with a $284.00 price target.<\/p>\n

Pacific Gas & Electric (PCG)<\/strong> \u2014 HSBC initiated coverage with a Buy rating and set a $15.50 price target.<\/p>\n

Palantir Technologies (PLTR)<\/strong> \u2014 Citigroup reiterated its Buy rating.<\/p>\n

Parabilis Medicines (PBLS)<\/strong> \u2014 HC Wainwright initiated coverage with a Buy rating and set a $40.00 price target.<\/p>\n

PBF Energy (PBF)<\/strong> \u2014 TD Cowen maintained its Hold rating and raised its price target to $75.00 from $73.00.<\/p>\n

Pebblebrook Hotel Trust (PEB)<\/strong> \u2014 Morgan Stanley set a price target of $15.00.<\/p>\n

Pegasystems (PEGA)<\/strong> \u2014 Barclays set a price target with a price target of $42.00, revised from $43.00.<\/p>\n

Pegasystems (PEGA)<\/strong> \u2014 DA Davidson set a price target of $35.00.<\/p>\n

Pegasystems (PEGA)<\/strong> \u2014 Royal Bank Of Canada reiterated its Outperform rating with a price target of $40.00, revised from $35.00.<\/p>\n

Pembina Pipeline (PBA)<\/strong> \u2014 Canadian Imperial Bank of Commerce downgraded the stock from Outperform to Neutral.<\/p>\n

Peoples Bancorp (PEBO)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and raised its price target to $48.00 from $46.00.<\/p>\n

Philip Morris International (PM)<\/strong> \u2014 Needham & Company LLC maintained its Buy rating and raised its price target to $220.00 from $215.00.<\/p>\n

Philip Morris International (PM)<\/strong> \u2014 UBS Group reiterated its Neutral rating with a $201.00 price target.<\/p>\n

Phillips 66 (PSX)<\/strong> \u2014 TD Cowen maintained its Buy rating and raised its price target to $308.00 from $295.00.<\/p>\n

Pinnacle West Capital (PNW)<\/strong> \u2014 HSBC initiated coverage with a Buy rating and set a $119.50 price target.<\/p>\n

PPL (PPL)<\/strong> \u2014 Bank of America reiterated its Buy rating.<\/p>\n

PPL (PPL)<\/strong> \u2014 HSBC initiated coverage with a Buy rating and set a $42.00 price target.<\/p>\n

Prudential Financial (PRU)<\/strong> \u2014 JPMorgan Chase & Co. maintained its Neutral rating and lowered its price target to $124.00 from $127.00.<\/p>\n

Public Service Enterprise Group (PEG)<\/strong> \u2014 HSBC initiated coverage with a Hold rating and set a $72.50 price target.<\/p>\n

Qiagen (QGEN)<\/strong> \u2014 Robert W. Baird maintained its Outperform rating and raised its price target to $52.00 from $50.00.<\/p>\n

Qiagen (QGEN)<\/strong> \u2014 JPMorgan Chase & Co. changed its rating from Overweight to Neutral with a price target of $52.00, revised from $55.00.<\/p>\n

Quanta Services (PWR)<\/strong> \u2014 The Goldman Sachs Group set a price target of $781.00.<\/p>\n

Quantinuum (QNT)<\/strong> \u2014 Rosenblatt Securities reiterated its Buy rating with a $155.00 price target.<\/p>\n

QuantumScape (QS)<\/strong> \u2014 Robert W. Baird maintained its Neutral rating and lowered its price target to $6.00 from $8.00.<\/p>\n

Rani Therapeutics (RANI)<\/strong> \u2014 Chardan Capital reiterated its Buy rating.<\/p>\n

RBB Bancorp (RBB)<\/strong> \u2014 Stephens reiterated its Positive rating.<\/p>\n

Reliance (RS)<\/strong> \u2014 Wells Fargo & Company maintained its Equal Weight rating and raised its price target to $420.00 from $391.00.<\/p>\n

Republic Services (RSG)<\/strong> \u2014 Robert W. Baird maintained its Neutral rating and raised its price target to $245.00 from $242.00.<\/p>\n

Riley Exploration Permian (REPX)<\/strong> \u2014 Roth Capital reiterated its Buy rating.<\/p>\n

Rithm Capital (RITM)<\/strong> \u2014 Wedbush reiterated its Outperform rating with a $10.00 price target.<\/p>\n

Rithm Property Trust (RPT)<\/strong> \u2014 Wedbush reiterated its Outperform rating with a $13.50 price target.<\/p>\n

Rogers (ROG)<\/strong> \u2014 B. Riley Financial maintained its Buy rating and lowered its price target to $195.00 from $225.00.<\/p>\n

Ross Stores (ROST)<\/strong> \u2014 Wolfe Research initiated coverage with a Outperform rating and set a $279 price target.<\/p>\n

SAP (SAP)<\/strong> \u2014 BMO Capital Markets maintained its Outperform rating and raised its price target to $265.00 from $235.00.<\/p>\n

SAP (SAP)<\/strong> \u2014 Jefferies Financial Group reiterated its Buy rating.<\/p>\n

SEI Investments (SEIC)<\/strong> \u2014 Morgan Stanley reiterated its Overweight rating with a $127.00 price target.<\/p>\n

SEI Investments (SEIC)<\/strong> \u2014 Piper Sandler reiterated its Overweight rating with a price target of $129.00, revised from $127.00.<\/p>\n

Sempra Energy (SRE)<\/strong> \u2014 HSBC initiated coverage with a Buy rating and set a $97.50 price target.<\/p>\n

SentinelOne (S)<\/strong> \u2014 DA Davidson set a price target of $20.00.<\/p>\n

SentinelOne (S)<\/strong> \u2014 Jefferies Financial Group reiterated its Buy rating.<\/p>\n

SentinelOne (S)<\/strong> \u2014 Susquehanna reiterated its Positive rating.<\/p>\n

SentinelOne (S)<\/strong> \u2014 Wedbush maintained its Outperform rating and raised its price target to $27.00 from $25.00.<\/p>\n

Shake Shack (SHAK)<\/strong> \u2014 UBS Group reiterated its Neutral rating with a $73.00 price target.<\/p>\n

Six Flags Entertainment (FUN)<\/strong> \u2014 Citizens Jmp maintained its Market Outperform rating and lowered its price target to $14.00 from $24.00.<\/p>\n

Sky Harbour Group (SKYH)<\/strong> \u2014 BTIG Research reiterated its Buy rating with a $13.00 price target.<\/p>\n

Soluna (SLNH)<\/strong> \u2014 Rosenblatt Securities maintained its Buy rating and lowered its price target with a $2.00 price target.<\/p>\n

South Bow (SOBO)<\/strong> \u2014 Canadian Imperial Bank of Commerce reiterated its Neutral rating with a $35.00 price target.<\/p>\n

Southern (SO)<\/strong> \u2014 HSBC initiated coverage with a Buy rating and set a $99.50 price target.<\/p>\n

SpaceX (SPCX)<\/strong> \u2014 Bank of America maintained its Buy rating and raised its price target to $275.00 from $235.00.<\/p>\n

Stifel Financial (SF)<\/strong> \u2014 Citigroup reiterated its existing rating with a $67.36 price target.<\/p>\n

Stifel Financial (SF)<\/strong> \u2014 JPMorgan Chase & Co. maintained its Neutral rating and lowered its price target to $80.00 from $82.00.<\/p>\n

Stifel Financial (SF)<\/strong> \u2014 UBS Group set a price target of $83.00.<\/p>\n

Symbotic (SYM)<\/strong> \u2014 TD Cowen maintained its Buy rating and lowered its price target to $70.00 from $75.00.<\/p>\n

Talen Energy (TLN)<\/strong> \u2014 HSBC initiated coverage with a Buy rating and set a $444.30 price target.<\/p>\n

Talen Energy (TLN)<\/strong> \u2014 TD Cowen initiated coverage with a Buy rating and set a $475.00 price target.<\/p>\n

TC Energy (TRP)<\/strong> \u2014 Canadian Imperial Bank of Commerce set a price target of $99.00.<\/p>\n

Teledyne Technologies (TDY)<\/strong> \u2014 Stifel Nicolaus maintained its Buy rating and raised its price target to $795.00 from $775.00.<\/p>\n

Tesla (TSLA)<\/strong> \u2014 BNP Paribas Exane upgraded the stock from Underperform to Neutral.<\/p>\n

Tesla (TSLA)<\/strong> \u2014 Canaccord Genuity Group set a price target of $442.00.<\/p>\n

Tesla (TSLA)<\/strong> \u2014 CLSA upgraded the stock from Underperform to Hold and set a $400 price target.<\/p>\n

Tesla (TSLA)<\/strong> \u2014 Glj Research reiterated its Sell rating.<\/p>\n

Tesla (TSLA)<\/strong> \u2014 JPMorgan Chase & Co. maintained its Neutral rating and raised its price target to $430.00 from $415.00.<\/p>\n

Tesla (TSLA)<\/strong> \u2014 Mizuho maintained its Outperform rating and raised its price target to $460.00 from $450.00.<\/p>\n

Tesla (TSLA)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and raised its price target to $410.00 from $400.00.<\/p>\n

Tesla (TSLA)<\/strong> \u2014 Needham & Company LLC reiterated its Hold rating.<\/p>\n

Tesla (TSLA)<\/strong> \u2014 Oppenheimer changed its rating from Market Perform to Outperform.<\/p>\n

Tesla (TSLA)<\/strong> \u2014 Piper Sandler reiterated its Overweight rating with a price target of $475.00, revised from $450.00.<\/p>\n

Tesla (TSLA)<\/strong> \u2014 Royal Bank Of Canada reiterated its Outperform rating with a $480.00 price target.<\/p>\n

Tesla (TSLA)<\/strong> \u2014 Stifel Nicolaus set a price target of $475.00.<\/p>\n

Tesla (TSLA)<\/strong> \u2014 TD Cowen reiterated its Buy rating with a $460.00 price target.<\/p>\n

Tesla (TSLA)<\/strong> \u2014 The Goldman Sachs Group reiterated its Neutral rating.<\/p>\n

Tesla (TSLA)<\/strong> \u2014 Tigress Financial initiated coverage with a Buy rating.<\/p>\n

Tesla (TSLA)<\/strong> \u2014 UBS Group reiterated its Neutral rating with a $425.00 price target.<\/p>\n

Texas Capital Bancshares (TCBI)<\/strong> \u2014 DA Davidson set a price target of $105.00.<\/p>\n

Texas Capital Bancshares (TCBI)<\/strong> \u2014 Piper Sandler maintained its Neutral rating and raised its price target to $101.00 from $100.00.<\/p>\n

Texas Capital Bancshares (TCBI)<\/strong> \u2014 Royal Bank Of Canada maintained its Sector Perform rating and lowered its price target to $110.00 from $113.00.<\/p>\n

Texas Instruments (TXN)<\/strong> \u2014 Barclays maintained its Equal Weight rating and raised its price target to $280.00 from $250.00.<\/p>\n

Texas Instruments (TXN)<\/strong> \u2014 Citigroup reiterated its Buy rating.<\/p>\n

Texas Instruments (TXN)<\/strong> \u2014 Jefferies Financial Group reiterated its Hold rating with a $300.00 price target.<\/p>\n

Texas Instruments (TXN)<\/strong> \u2014 JPMorgan Chase & Co. maintained its Overweight rating and raised its price target to $365.00 from $340.00.<\/p>\n

Texas Instruments (TXN)<\/strong> \u2014 Mizuho maintained its Neutral rating and lowered its price target to $290.00 from $305.00.<\/p>\n

Texas Instruments (TXN)<\/strong> \u2014 Morgan Stanley reiterated its Underweight rating with a $278.00 price target.<\/p>\n

Texas Instruments (TXN)<\/strong> \u2014 Rosenblatt Securities maintained its Buy rating and raised its price target to $360.00 from $350.00.<\/p>\n

Texas Instruments (TXN)<\/strong> \u2014 Stifel Nicolaus maintained its Buy rating and raised its price target to $370.00 from $360.00.<\/p>\n

Texas Instruments (TXN)<\/strong> \u2014 Susquehanna reiterated its Positive rating.<\/p>\n

Texas Instruments (TXN)<\/strong> \u2014 The Goldman Sachs Group reiterated its Sell rating with a $250.00 price target.<\/p>\n

Texas Instruments (TXN)<\/strong> \u2014 Truist Financial set a price target of $305.00.<\/p>\n

Texas Instruments (TXN)<\/strong> \u2014 UBS Group reiterated its Buy rating.<\/p>\n

Thermo Fisher Scientific (TMO)<\/strong> \u2014 Robert W. Baird maintained its Outperform rating and raised its price target to $756.00 from $723.00.<\/p>\n

Thermo Fisher Scientific (TMO)<\/strong> \u2014 Barclays maintained its Overweight rating and raised its price target to $775.00 from $750.00.<\/p>\n

Thermo Fisher Scientific (TMO)<\/strong> \u2014 Royal Bank Of Canada maintained its Sector Perform rating and raised its price target to $730.00 from $580.00.<\/p>\n

Thermo Fisher Scientific (TMO)<\/strong> \u2014 Stifel Nicolaus maintained its Buy rating and raised its price target to $775.00 from $650.00.<\/p>\n

Thermo Fisher Scientific (TMO)<\/strong> \u2014 TD Cowen maintained its Buy rating and raised its price target to $810.00 from $760.00.<\/p>\n

Thermo Fisher Scientific (TMO)<\/strong> \u2014 UBS Group reiterated its Buy rating with a $800.00 price target.<\/p>\n

TJX Companies (TJX)<\/strong> \u2014 Wolfe Research initiated coverage with a Peer Perform rating.<\/p>\n

Travel + Leisure (TNL)<\/strong> \u2014 Morgan Stanley reiterated its Overweight rating with a $86.00 price target.<\/p>\n

Ultrapar Participacoes (UGP)<\/strong> \u2014 JPMorgan downgraded the stock from Overweight to Neutral.<\/p>\n

United Airlines (UAL)<\/strong> \u2014 Argus maintained its Buy rating and lowered its price target to $125.00 from $140.00.<\/p>\n

United Airlines (UAL)<\/strong> \u2014 BMO Capital Markets reiterated its Outperform rating with a price target of $135.00, revised from $140.00.<\/p>\n

United Airlines (UAL)<\/strong> \u2014 Susquehanna maintained its Positive rating and lowered its price target to $130.00 from $150.00.<\/p>\n

United Airlines (UAL)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and lowered its price target to $155.00 from $160.00.<\/p>\n

United Rentals (URI)<\/strong> \u2014 Bank of America reiterated its Buy rating.<\/p>\n

United Rentals (URI)<\/strong> \u2014 UBS Group reiterated its Buy rating with a $1,450.00 price target.<\/p>\n

United Therapeutics (UTHR)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and lowered its price target to $697.00 from $708.00.<\/p>\n

UnitedHealth Group (UNH)<\/strong> \u2014 Mizuho maintained its Outperform rating and raised its price target to $500.00 from $493.00.<\/p>\n

Urban Outfitters (URBN)<\/strong> \u2014 Wolfe Research initiated coverage with a Peer Perform rating.<\/p>\n

Valero Energy (VLO)<\/strong> \u2014 TD Cowen maintained its Hold rating and raised its price target to $400.00 from $375.00.<\/p>\n

Veradermics (MANE)<\/strong> \u2014 B. Riley Financial maintained its Buy rating and raised its price target to $204.00 from $170.00.<\/p>\n

Veradermics (MANE)<\/strong> \u2014 UBS Group set a price target of $204.00.<\/p>\n

Viking (VIK)<\/strong> \u2014 Morgan Stanley set a price target of $94.00.<\/p>\n

Vistra (VST)<\/strong> \u2014 HSBC initiated coverage with a Buy rating and set a $190.00 price target.<\/p>\n

Vita Coco (COCO)<\/strong> \u2014 William Blair reiterated its Market Perform rating.<\/p>\n

Weatherford International (WFRD)<\/strong> \u2014 Barclays maintained its Overweight rating and lowered its price target to $139.00 from $148.00.<\/p>\n

Weatherford International (WFRD)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and lowered its price target to $123.00 from $124.00.<\/p>\n

WEC Energy Group (WEC)<\/strong> \u2014 HSBC initiated coverage with a Hold rating and set a $106.50 price target.<\/p>\n

WeRide (WRD)<\/strong> \u2014 Barclays initiated coverage with a Equal Weight rating and set a $4.00 price target.<\/p>\n

Western Alliance Bancorporation (WAL)<\/strong> \u2014 Stephens reiterated its existing rating with a $76.71 price target.<\/p>\n

WhiteHorse Finance (WHF)<\/strong> \u2014 Raymond James upgraded the stock from Market Perform to Outperform and set a $9 price target.<\/p>\n

Wingstop (WING)<\/strong> \u2014 Robert W. Baird maintained its Outperform rating and lowered its price target to $150.00 from $160.00.<\/p>\n

Wingstop (WING)<\/strong> \u2014 DA Davidson set a price target of $180.00.<\/p>\n

Winnebago Industries (WGO)<\/strong> \u2014 BMO Capital Markets maintained its Outperform rating and lowered its price target to $33.00 from $38.00.<\/p>\n

Wyndham Hotels & Resorts (WH)<\/strong> \u2014 Morgan Stanley set a price target of $97.00.<\/p>\n

Wyndham Hotels & Resorts (WH)<\/strong> \u2014 Stifel Nicolaus maintained its Buy rating and raised its price target to $99.00 from $98.00.<\/p>\n

Xcel Energy (XEL)<\/strong> \u2014 HSBC initiated coverage with a Buy rating and set a $89.00 price target.<\/p>\n

XTI Aerospace (XTIA)<\/strong> \u2014 Maxim Group set a price target of $2.00.<\/p>\n

Zimmer Biomet (ZBH)<\/strong> \u2014 Argus reiterated its Buy rating with a $125.00 price target.<\/p>\n

Zoom Communications (ZM)<\/strong> \u2014 Needham & Company LLC reiterated its Buy rating with a $130.00 price target.<\/p>\n","protected":false},"excerpt":{"rendered":"

Analyst Ratings (USA) American analyst sentiment remains cautiously optimistic but increasingly selective, with strong interest in utilities, power generation, defence, healthcare, and infrastructure-related sectors.…<\/p>\n","protected":false},"author":3,"featured_media":76540,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-76523","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"acf":[],"yoast_head":"\nUS Analyst Updates: October 22nd, 2026 | Stock Target Advisor<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-22nd-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"US Analyst Updates: October 22nd, 2026\" \/>\n<meta property=\"og:description\" content=\"Analyst Ratings (USA) American analyst sentiment remains cautiously optimistic but increasingly selective, with strong interest in utilities, power generation, defence, healthcare, and infrastructure-related sectors.…\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-22nd-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Stock Target Advisor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-22T20:37:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2026\/10\/IBM-Tesla-and-Meta-Market-Banner.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1672\" \/>\n\t<meta property=\"og:image:height\" content=\"941\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"STA Research\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:site\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"STA Research\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"29 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-22nd-2026\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-22nd-2026\/\"},\"author\":{\"name\":\"STA Research\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\"},\"headline\":\"US Analyst Updates: October 22nd, 2026\",\"datePublished\":\"2026-10-22T20:37:30+00:00\",\"dateModified\":\"2026-10-22T20:37:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-22nd-2026\/\"},\"wordCount\":6078,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"articleSection\":[\"Market News & Insights\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-22nd-2026\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-22nd-2026\/\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-22nd-2026\/\",\"name\":\"US Analyst Updates: October 22nd, 2026 | Stock Target Advisor\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\"},\"datePublished\":\"2026-10-22T20:37:30+00:00\",\"dateModified\":\"2026-10-22T20:37:30+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-22nd-2026\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-22nd-2026\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-22nd-2026\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"US Analyst Updates: October 22nd, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"name\":\"Stock Target Advisor\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\",\"name\":\"Stock Target Advisor\",\"alternateName\":\"STA\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"contentUrl\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"width\":\"225\",\"height\":\"225\",\"caption\":\"Stock Target Advisor\"},\"image\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\",\"https:\/\/twitter.com\/AdvisorTarget\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\",\"name\":\"STA Research\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"caption\":\"STA Research\"},\"description\":\"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"US Analyst Updates: October 22nd, 2026 | Stock Target Advisor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-22nd-2026\/","og_locale":"en_US","og_type":"article","og_title":"US Analyst Updates: October 22nd, 2026","og_description":"Analyst Ratings (USA) American analyst sentiment remains cautiously optimistic but increasingly selective, with strong interest in utilities, power generation, defence, healthcare, and infrastructure-related sectors.…","og_url":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-22nd-2026\/","og_site_name":"Stock Target Advisor","article_publisher":"https:\/\/www.facebook.com\/StockTargetAdvisor\/","article_published_time":"2026-10-22T20:37:30+00:00","og_image":[{"width":1672,"height":941,"url":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2026\/10\/IBM-Tesla-and-Meta-Market-Banner.png","type":"image\/png"}],"author":"STA Research","twitter_card":"summary_large_image","twitter_creator":"@AdvisorTarget","twitter_site":"@AdvisorTarget","twitter_misc":{"Written by":"STA Research","Est. reading time":"29 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-22nd-2026\/#article","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-22nd-2026\/"},"author":{"name":"STA Research","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae"},"headline":"US Analyst Updates: October 22nd, 2026","datePublished":"2026-10-22T20:37:30+00:00","dateModified":"2026-10-22T20:37:30+00:00","mainEntityOfPage":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-22nd-2026\/"},"wordCount":6078,"commentCount":0,"publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"articleSection":["Market News & Insights"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-22nd-2026\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-22nd-2026\/","url":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-22nd-2026\/","name":"US Analyst Updates: October 22nd, 2026 | Stock Target Advisor","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website"},"datePublished":"2026-10-22T20:37:30+00:00","dateModified":"2026-10-22T20:37:30+00:00","breadcrumb":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-22nd-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-22nd-2026\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-22nd-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.stocktargetadvisor.com\/blog\/"},{"@type":"ListItem","position":2,"name":"US Analyst Updates: October 22nd, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","name":"Stock Target Advisor","description":"","publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization","name":"Stock Target Advisor","alternateName":"STA","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/","url":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","contentUrl":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","width":"225","height":"225","caption":"Stock Target Advisor"},"image":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/StockTargetAdvisor\/","https:\/\/twitter.com\/AdvisorTarget"]},{"@type":"Person","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae","name":"STA Research","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","caption":"STA Research"},"description":"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.","url":"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/"}]}},"_links":{"self":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/76523","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/comments?post=76523"}],"version-history":[{"count":4,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/76523\/revisions"}],"predecessor-version":[{"id":76543,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/76523\/revisions\/76543"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media\/76540"}],"wp:attachment":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media?parent=76523"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/categories?post=76523"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/tags?post=76523"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}